| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022417 |
| Receipt No. | R000025484 |
| Scientific Title | A study to test the efficacy of "mulberry leaf green juice" in improving constipation in pregnant females. |
| Date of disclosure of the study information | 2016/05/25 |
| Last modified on | 2020/06/01 (Ver. 8) |
| Basic information | ||
| Public title | A study to test the efficacy of "mulberry leaf green juice" in improving constipation in pregnant females. | |
| Acronym | A study to test the efficacy of "mulberry leaf green juice" in improving constipation. | |
| Scientific Title | A study to test the efficacy of "mulberry leaf green juice" in improving constipation in pregnant females. | |
| Scientific Title:Acronym | A study to test the efficacy of "mulberry leaf green juice" in improving constipation. | |
| Region |
|
|
| Condition | ||||
| Condition | People tend to be constipated | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to examine the safety and efficacy in ameliorating constipation of green mulberry leaf juice administered for 2 to 12 weeks in pregnant women suffering from constipation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Daily defecation frequency
(amount of defecation, Bristol Stool Form Scale, stool color and smell, feeling after defection) |
| Key secondary outcomes | Intestinal bacteria flora
Dietary survey (The brief-type self-administered diet history questionnaire) Questionnaire survey Safety assessment |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Ingested food : Mulberry leaf green juice
Dose : Two packets per day Drink Usage : The content of each package should be fully dissolved in 100 to 180 mL of cold or hot water before ingestion. Period : 2-12 weeks |
||
| Interventions/Control_2 | Ingested drugs : Magnesium oxide
Dose : 1.5 g per day Usage : The control product should be taken with water at a daily dose of 1.5 g in 3 divided doses, or in a single dose before going to bed. Period : 2-12 weeks |
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Pregnant women aged 18 to < 45 years reporting constipation.
2) Those who express their willingness to participate in the study and provide consent for participation after understanding the purpose and details of the study. 3) Those who can continue to undergo antenatal checkups at the study site. |
|||
| Key exclusion criteria | 1) Those currently attending the hospital for the treatment of other diseases.
2) Those with diseases that might affect the results of assessment in this study. 3) Those currently taking foods or green juice containing mulberry leaf regularly. 4) Those currently participating in another clinical trial or have participated in another clinical trial within 3 months prior to the start of the present study. 5) Other women judged by the attending physicians as being inappropriate candidates for inclusion in the study. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Niigata University of Health and Welfare
|
||||||
| Division name | Department of Health and Nutrition | ||||||
| Zip code | 950-3198 | ||||||
| Address | 1398 Shimami-cho, Kita-ku, Niigata-shi, Niigata, 950-3198, JAPAN | ||||||
| TEL | 025-257-4494 | ||||||
| yuna-watanabe@nuhw.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | NATURAL SCIENCE CORPORATION | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | 136-0037 | ||||||
| Address | 3F NATURAL FACTORY TOKYO, 3-4-27 Kitasuna, Koto-ku, Tokyo 136-0073, JAPAN | ||||||
| TEL | 03-5665-2311 | ||||||
| Homepage URL | |||||||
| ando@natural-s.jp | |||||||
| Sponsor | |
| Institute | Natural Science Co.,Ltd.
Research and Development Department |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Healthcare Systems Co., Ltd. |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Niigata University of Health and Welfare IRB |
| Address | 1398 Shimami-cho, Kita-ku, Niigata-shi, Niigata, 950-3198, JAPAN |
| Tel | 025-257-4455 |
| eri-sakata@nuhw.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | よしかた産婦人科 (神奈川県)
Yoshikata Obsterics and Gynecology Clinic (Kanagawa) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | To be reported at the 33rd Annual Scientific Meeting of the Japan Society for Menopause and Women's Health, November 3-4, 2018 |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025484 |